... "The moment I received my official diagnosis, I dropped all my assumptions about HIV. It was so freeing." -Member of myHIVteamLiving with a chronic condition can be difficult and even a burden, but also an opportunity to rid yourself of what you think you know. Have you heard the saying, "People don't get it until they get it"? ...
Beginner's Mind - Not Knowing It All When Living with HIV
... "The moment I received my official diagnosis, I dropped all my assumptions about HIV. It was so freeing." -Member of myHIVteamLiving with a chronic condition can be difficult and even a burden, but also an opportunity to rid yourself of what you think you know. Have you heard the saying, "People don't get it until they get it"? ...
... I love those that I don’t even like, and that’s very hard to do, but it’s how I learn to love myself in the midst of it all.”Another member shared their journey to self-acceptance over time: “Back then, I had created a separate person and even adopted a different name, Dave, instead of David. ...
Has Having HIV Split the Public You From the Private You?
... I love those that I don’t even like, and that’s very hard to do, but it’s how I learn to love myself in the midst of it all.”Another member shared their journey to self-acceptance over time: “Back then, I had created a separate person and even adopted a different name, Dave, instead of David. ...
... References Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention: A Randomized Trial — Annals of Internal Medicine Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention — Reprivetrial.org Having Three or More Metabolic Risk Factors ...
Preventing Diabetes With HIV: Study Reveals 4 Early Risks
... References Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention: A Randomized Trial — Annals of Internal Medicine Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention — Reprivetrial.org Having Three or More Metabolic Risk Factors ...
... — HIV.gov Head-to-Head Comparison of Accuracy of a Rapid Point-of-Care HIV Test With Oral Versus Whole-Blood Specimens: A Systematic Review and Meta-Analysis — Database of Abstracts of Reviews of Effects (DARE) ...
... It gave me strength to fight and demand representation... to this very day.It all took a toll on me back in 1994, when I felt alone and against a wall. With no support and AIDS cases rising, I dove into a depression and became self-destructive. Being diagnosed with an HIV strain that was destroying my organs, I rose up and regained my spirit. ...
How an AIDS-related Form of Cancer Changed My World Forever
... It gave me strength to fight and demand representation... to this very day.It all took a toll on me back in 1994, when I felt alone and against a wall. With no support and AIDS cases rising, I dove into a depression and became self-destructive. Being diagnosed with an HIV strain that was destroying my organs, I rose up and regained my spirit. ...
... That is a life we all deserve.My words of wisdom to you: Go live your life! Be positive! Be loving and free to be the best you that you can be! This article was written by Michael A. Hellman, a myHIVteam member, as part of the Member Spotlight Series.Do you want to be a part of the myHIVteam Member Spotlight Series? ...
HIV Member Spotlight: On the Bright Side
... That is a life we all deserve.My words of wisdom to you: Go live your life! Be positive! Be loving and free to be the best you that you can be! This article was written by Michael A. Hellman, a myHIVteam member, as part of the Member Spotlight Series.Do you want to be a part of the myHIVteam Member Spotlight Series? ...
... Low risk — Zidovudine treatment for two weeks Medium risk — Zidovudine treatment for four to six weeks High risk — HIV therapy with three-drug treatment from birth for two to six weeks; if less than six weeks, continued use of zidovudine alone to complete six weeks of therapy Breastfeeding In the past, health experts did not recommend that an HIV-positive ...
HIV and Pregnancy: Preventing Transmission
... Low risk — Zidovudine treatment for two weeks Medium risk — Zidovudine treatment for four to six weeks High risk — HIV therapy with three-drug treatment from birth for two to six weeks; if less than six weeks, continued use of zidovudine alone to complete six weeks of therapy Breastfeeding In the past, health experts did not recommend that an HIV-positive ...
... Neurocognitive Performance in Previously Antiretroviral-Naive HIV-Infected Individuals on Their First Suppressive Regimen — AIDS Issues in HIV/AIDS in Adults in Palliative Care — Wolters Kluwer UpToDate The Prevalence of Comorbidities Among People Living With HIV in Brent: A Diverse London Borough — London Journal of Primary Care One Size Does Not Fit All ...
Aging With HIV: 5 Problems To Watch For
... Neurocognitive Performance in Previously Antiretroviral-Naive HIV-Infected Individuals on Their First Suppressive Regimen — AIDS Issues in HIV/AIDS in Adults in Palliative Care — Wolters Kluwer UpToDate The Prevalence of Comorbidities Among People Living With HIV in Brent: A Diverse London Borough — London Journal of Primary Care One Size Does Not Fit All ...